2. "RE: Less Cancer in Huntington's Disease Patients"
In response to message #1
I researched this, and finally contacted the author, Dr. Sven Asger Sørensen. This is the most important part of the message:
DCA has been used in many studies to investigate its effect on Huntington's disease (HD). But all these studies have been for scientific purposes and have only involved animals (mostly mice) transgenic for the HD-gene. To the best of my knowledge DCA has never been used for treatment of HD in human beings.
So DCA is NOT connected to the lower cancer rate in HD patients.
3. "RE: Less Cancer in Huntington's Disease Patients"
In response to message #2
Jim, I may have been mistaken about the human studies, will have to look into that. I was researching DMG (dimethylglycine) at the same time (which is used to treat Huntington's Disease), both of which are present in pangamic acid (Vitamin B-15). I'm curious as to whether DMG would act synergistically with DCA. DMG is a methylating agent, it reduces lactic acid, improves oxygenation and immune function.